Israel wants flu vax made at home

The Israeli health ministry isn't content with contracting to buy vaccines against H1N1 "swine" flu; instead, the government has started negotiating with domestic pharma companies to set up a plant to make the shots in-country. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.